Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Pocket Test Measures Fifty Diagnostic Parameters

By LabMedica International staff writers
Posted on 03 Jan 2013
A small device could allow health care providers to test for insulin and other blood proteins, cholesterol, and even signs of viral or bacterial infection simultaneously. More...


The novel device is about the size of a business card and is called the multiplexed volumetric bar-chart chip or V-chip and uses as little as one µL of blood for all the point-of-care- tests.

Scientists at the Methodist Hospital Research Institute (Houston, TX, USA) developed the V-chip, which is composed of two thin pieces of glass that are about 7.6 cm by 5.1 cm. In between are four wells: for hydrogen peroxide; for up to 50 different antibodies to specific proteins, DNA or RNA fragments, or lipids of interest, and the enzyme catalase; for serum or other sample; and for a suitable dye. Initially, the wells are kept separate from each other. A shift in the glass plates brings the wells into contact, creating a contiguous, zigzagged space from one end of the V-chip to the other.

When the substance of interest, such as insulin, binds to antibodies bound to the glass slide, catalase is made active and splits nearby hydrogen peroxide into water and oxygen gas. This approach resembles enzyme-linked immunosorbent assay (ELISA) methods. The oxygen pushes the dye up the column. The more insulin present, the more oxygen is created, and the farther dye is pushed up the slide. Tests show that distance is more or less proportional to the amount of substrate present. The end result is a visual bar chart. The device is easy to read and accurate.

Lidong Qin, PhD, the project's principal investigator, said, "The V-Chip could make it possible to bring tests to the bedside, remote areas, and other types of point-of-care needs. V-Chip is accurate, cheap, and portable. It requires only a drop of a sample, not a vial of blood, and can do 50 different tests in one go. The sensitivity of the V-chip can be improved if narrower and longer bar channels are used. Our next steps are to make the device more user friendly and be so simple to use, it barely needs instructions." The study was published on December 18, 2012, in the journal Nature Communications.

The Methodist Hospital Research Institute


Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Hematology Analyzer
Medonic M32B
Capillary Blood Collection Tube
IMPROMINI M3
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.